ArticleBMC psychology2026
Analysis of alexithymia and resilience levels in young breast cancer patients following modified radical mastectomy.
Article in BMC psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aims to investigate the correlation between alexithymia and resilience levels in young breast cancer patients after undergoing modified radical mastectomy.
methodsA prospective study was conducted on 70 young breast cancer patients, who were categorized based on the Toronto Alexithymia Scale-20 (TAS-20) scores into: non-alexithymia group (n = 24); moderate alexithymia group (n = 32); and severe alexithymia group (n = 14). The Toronto Alexithymia Scale-20 (TAS-20) and the Connor-Davidson Resilience Scale (CD-RISC) were utilized for evaluation to analyze the relationship between alexithymia and resilience levels post-modified radical mastectomy.
resultsIn this study, the CD-RISC scores for the non-alexithymia group were 85.32 ± 7.65, for the moderate alexithymia group were 72.45 ± 8.32, and for the severe alexithymia group were 58.96 ± 9.13. The differences in CD-RISC scores among the three groups were statistically significant (P < 0.001), with the scores decreasing from the non-alexithymia group to the moderate and then to the severe group. Correlation analysis showed a negative correlation between the total and dimensional scores of TAS-20 and the total and dimensional scores of CD-RISC (-0.667 < r<-0.200, P < 0.05).
conclusionYoung breast cancer patients exhibit a moderate level of alexithymia post-modified radical mastectomy, which negatively correlates with their level of psychological resilience. Clinically, appropriate intervention measures can be implemented based on the patients’ conditions to enhance their psychological resilience and alleviate alexithymia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.